metanephrine has been researched along with neuropeptide y in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Azizi, M; Chatellier, G; Comoy, E; Corvol, P; Denolle, T; Grouzmann, E; Plouin, PF | 1 |
| Brunner, H; Buclin, T; Cavadas, C; de Torrenté, A; Fathi, M; Gillet, M; Grouzmann, E | 1 |
| Abid, K; Beuschlein, F; Bilz, S; Brown, NJ; Eugster, PJ; Fischli, S; Grouzmann, E; Henzen, C; Hubers, SA; Kolb, W; Matter, M; Maurer, J; Nölting, S; Reul, A; Schütze, I; Sigrist, S; Trepp, R; Vocat, C; Wuerzner, G | 1 |
3 other study(ies) available for metanephrine and neuropeptide y
| Article | Year |
|---|---|
Plasma neuropeptide Y and catecholamine concentrations and urinary metanephrine excretion in patients with adrenal or ectopic phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Catecholamines; Choristoma; Diagnosis, Differential; Humans; Metanephrine; Neuropeptide Y; Pheochromocytoma | 1991 |
Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma.
Topics: Catecholamines; Female; Half-Life; Humans; Male; Metanephrine; Neuropeptide Y; Pheochromocytoma | 2001 |
Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma.
Topics: Adrenal Gland Neoplasms; Healthy Volunteers; Humans; Metanephrine; Neuropeptide Y; Paraganglioma; Pheochromocytoma; Protein Precursors; Tandem Mass Spectrometry | 2022 |